The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 30, 2001

Primary Completion Date

December 9, 2011

Study Completion Date

December 9, 2011

Conditions
Major Depressive DisorderBipolar Disorder
Interventions
OTHER

chronobiological augmentation

Sleep deprivation for one night, Chronobiological augmentation consists of partial sleep phase advance for three nights and Light therapy for two hours for three days

DRUG

sertraline, lithium

"Antidepressant, Subjects will be started on a serotonin specific reuptake inhibitor (SSRI), sertraline 100 mg (50mg hs x 2) daily or other SSRI's such as Paxil 20 mg or Prozac 20 mg daily and continue treatment for seven weeks.~Mood stabilizer, subjects will be treated with lithium 450 mg twice a day or another mood stabilizer such as depakote or valproate and continue treatment for seven weeks."

RADIATION

one night of sleep deprivation and two FDG PET scans

MDD Mechanism Only depressed subjects will have two FDG PET scans consisting of a baseline FDG PET scan and a sleep deprived FDG PET scan. One night of regular sleep,one night of sleep deprivation and one night of recovery sleep for a total of four nights at a sleep laboratory facility.

Trial Locations (2)

92697

University of California, Irvine, Irvine

92093 - 0603

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

University of California, Irvine

OTHER

NCT00581009 - The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients | Biotech Hunter | Biotech Hunter